“Vasomotor Symptoms Epidemiology” has been added to DelveInsight
Overview of Vasomotor Symptoms epidemiology, pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies
Request free sample copy here- https://www.delveinsight.com/sample-request/vasomotor-symptoms-hot-flashes-night-sweats-epidemiology-insights
Important facts of Vasomotor Symptoms epidemiology report
- Among the European countries, Germany had highest prevalent population of Vasomotor Symptoms, followed by France. On the other hand, Spain had the lowest prevalent population of Vasomotor Symptoms.
- As per the estimates, the United States has the highest prevalent population of hot flashes associated with post menopause with 18,926,632 cases in 2018. Japan had the lowest prevalent population with 4,553,108 prevalent cases of hot flashes in 2018.
- Women in France exhibited a higher prevalence of hot flushes at ages 55 to 64 years compared with ages 45 to 54 years. On the other hand, night Sweats have been observed to decrease with age in all countries.
Vasomotor Symptoms Treatment
Prescription systemic estrogen-containing products remain the therapeutic standard for moderate to severe menopause-related hot flashes. Recommended options for women with concerns or contraindications relating to estrogen-containing treatments include prescription progestogens, venlafaxine, paroxetine, fluoxetine, or gabapentin. Although paroxetine (Paxil) is the only nonhormonal medication approved by the US FDA for this indication.
Vasomotor Symptoms Epidemiology Report
VMS are a form of temperature dysfunction that occurs due to changes in gonadal hormones. Normally, core body temperature (CBT) remains within a specific range, oscillating with daily circadian rhythms. Physiological processes that conserve and dissipate heat are responsible for maintaining CBT, and tight regulation is important for maintenance of optimal internal organ function. Disruption of this tightly controlled temperature circuit results in exaggerated heat-loss responses and presents as VMS. The mechanistic role related to changes in gonadal hormones associated with VMS is not understood.
Vasomotor Symptoms Epidemiology: Report Scope
- The Vasomotor symptoms (Hot flashes/Night sweats) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Report and Model provide an overview of the risk factors and global trends of Vasomotor symptoms (Hot flashes/Night sweats) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight about the historical and forecasted patient pool of Vasomotor symptoms (Hot flashes/Night sweats) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) and Japan
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Vasomotor symptoms
- The report provides the segmentation of the Vasomotor symptoms (Hot flashes/Night sweats) epidemiology by -specific Prevalent Cases of Vasomotor symptoms (Hot flashes/Night sweats) in 7MM
- The report provides the segmentation of the Vasomotor symptoms (Hot flashes/Night sweats) epidemiology by Gender-specific Cases of Vasomotor symptoms (Hot flashes/Night sweats) in 7MM
Following is the table of content of Vasomotor Symptoms Epidemiology Report
1. Key Insights
2. Vasomotor Symptoms (Hot Flashes/Night Sweats): Epidemiology Overview at a Glance
3. Executive summary
4. Organizations
5. Epidemiology Methodology
6. Vasomotor Symptoms (VMS) associated with menopause: Disease Background and Overview
7. Epidemiology and Patient Population
8. Total Prevalent cases of Vasomotor Symptoms (Hot Flashes/Night Sweats) in Post-menopause in 7MM
9. Country Wise-Epidemiology of Hot Flashes Associated with Post-menopause
10. KOL Views
11. Appendix
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
Vasomotor Symptoms: Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global Vasomotor symptoms (Hot flashes/Night sweats) market
- Quantify patient populations in the global Vasomotor symptoms (Hot flashes/Night sweats) market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for vasomotor symptoms (Hot flashes/Night sweats) therapeutics in each of the markets covered
- Understand the magnitude of Vasomotor symptoms (Hot flashes/Night sweats) population by its severity
- The Vasomotor symptoms (Hot flashes/Night sweats) epidemiology report and model were written and developed by Masters and PhD level epidemiologists
- The Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Related Reports
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
